James Mullen
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
James C. Mullen is een zakenman die aan het roer heeft gestaan van 11 verschillende bedrijven en momenteel de positie bekleedt van niet-uitvoerend Voorzitter bij Percivia LLC, Voorzitter, President & Chief Executive Officer van Editas Medicine, Inc. en Chief Executive Officer voor DPx Holdings BV. Hij is tevens lid van de raad van bestuur van Thermo Fisher Scientific, Inc. en The Rivers School Corp. en lid van Biomedical Sciences Careers Program, Inc. In het verleden bekleedde James C. Mullen de functie van Uitvoerend Voorzitter bij Vicarius Pharma AG, President, Chief Executive Officer & Director bij Biogen, Inc. Bestuurder bij Biogen Idec, Inc. (Noord-Carolina) en President bij Biogen Idec New Ventures, Inc. (beide zijn dochterondernemingen van Biogen, Inc.), Voorzitter bij Torque Therapeutics, Inc., Chief Executive Officer & niet-onafhankelijk Bestuurder bij Patheon, Inc., Chief Executive Officer & uitvoerend Bestuurder bij Patheon NV, Principal bij GlaxoSmithKline LLC en Voorzitter voor Biotechnology Innovation Organization. Hij behaalde een MBA aan de Villanova University en een bachelorgraad aan het Rensselaer Polytechnic Institute.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-02-2026 | 3.393 ( 0% ) | 2 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Biomedical Sciences Careers Program, Inc. | Corporate Officer/Principal | - |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Voorzitter | - |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | - |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Directeur/Bestuurslid | 20-05-2026 |
| EDITAS MEDICINE, INC. | Algemeen Directeur | 01-06-2022 |
| INSULET CORPORATION | Directeur/Bestuurslid | 28-01-2019 |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Voorzitter | 25-01-2019 |
| PATHEON N.V. | Algemeen Directeur | 29-08-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 19 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Commercial Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Retail Trade |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Commercial Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau